Defective PMM2 causes PMM2-CDG (CDG-1a)

Stable Identifier
R-HSA-4043911
Type
Pathway
Species
Homo sapiens
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this pathway in the Pathway Browser

Phosphomannomutase 2 (PMM2) normally catalyses the isomerisation of mannose 6-phosphate (Man6P) to mannose 1-phosphate (Man1P) in the cytosol of cells. Man1P is a precursor in the synthesis of GDP-mannose and dolichol-phosphate-mannose, required for critical mannosyl transfer reactions in the N-glycosylation of proteins. Mutations in the PMM2 gene are one of the causes of Jaeken syndrome, a congenital disorder of glycosylation type 1a (PMM2-CDG, previously CDG-1a) (Matthijs et al. 1997). PMM2-CDG was first described in Belgian identical twin sisters, characterized by psychomotor retardation and multiple serum glycoprotein abnormalities. Serum and CSF transferrin were found to be deficient in sialic acid (Jaeken et al. 1984). PMM2-CDG is the most common CDG disease subtype.

Literature References
PubMed ID Title Journal Year
6543331 Sialic acid-deficient serum and cerebrospinal fluid transferrin in a newly recognized genetic syndrome

Jaeken, J, van Eijk, HG, van der Heul, C, Corbeel, L, Eeckels, R, Eggermont, E

Clin. Chim. Acta 1984
9140401 Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome)

Matthijs, G, Schollen, E, Pardon, E, Veiga-da-Cunha, M, Jaeken, J, Cassiman, JJ, Van Schaftingen, E

Nat Genet 1997
Participants
Participant Of
Disease
Name Identifier Synonyms
congenital disorder of glycosylation type I 0050570
Authored
Reviewed
Created
Cite Us!